ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET ANALYSIS

Antimicrobial Susceptibility Testing Market, By Product Type (Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, and Consumables), By Application (Antibacterial, Antifungal, Anti-parasitic, and Antiviral), By Method (Disk Diffusion, Rapid Automated AST, Broth Dilution, Gradient Diffusion, and Genotypic Methods), By End User (Hospitals, Pathology/Diagnostic Laboratories, Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : May 2024
Code : CMI2449
Pages :258
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Regional Analysis

Antimicrobial Susceptibility Testing Market Regional Insights

To learn more about this report, request sample copy

North America remains the dominant region in the global antimicrobial susceptibility testing market, and it is estimated to hold 36.4% of the market share in 2024. The presence of major market players and advanced healthcare infrastructure in the region has contributed significantly to its large market size. Countries like the U.S. have a highly developed pharmaceutical sector and increasing healthcare spending, which has translated to higher demand for diagnostic procedures like antimicrobial susceptibility testing. Moreover, rising antibiotic resistance in the region is prompting healthcare providers to frequently monitor the effectiveness of treatments, thereby driving the need for susceptibility testing services. Many leading diagnostic product manufacturers are also headquartered in North America, allowing for easy access to cutting-edge testing solutions.

The Asia Pacific region is poised to be the fastest growing market for antimicrobial susceptibility testing. Factors such as the enlarging patient population, growing medical tourism industry, and improving access to healthcare have served to strengthen the regional market in recent times. Countries like India, China, and Japan housed over half the world's population and are experiencing immense economic development. This has prompted higher government spending on modernizing their national healthcare systems. Rising affluence has also pushed citizens to spend more on their health. The expanding diagnostics industry in Asia Pacific benefits from low-cost manufacturing environments and a large skilled workforce, gaining a competitive edge in the global exports market for antimicrobial susceptibility testing tools. Local diagnostic firms are investing in R&D to cater to the indigenous demand as well as exploring overseas opportunities.